CSIMarket
 
Allogene Therapeutics Inc   (NASDAQ: ALLO)
 

Allogene Therapeutics Inc's Customers Performance

ALLO



 
ALLO's Source of Revenues During the corresponding time, Allogene Therapeutics Inc recorded a revenue increase by 567.5 % year on year, sequentially revenue grew by 567.5 %. While revenue at the Allogene Therapeutics Inc 's corporate clients

List of ALLO Customers




for the same period Allogene Therapeutics Inc recorded revenue increase by 567.5 % year on year, sequentially revenue grew by 567.5 %.

List of ALLO Customers

Allogene Therapeutics Inc's Business Units
Reportable    86.89 % of total Revenue






Allogene Therapeutics Inc's Comment on Sales, Marketing and Customers



The company serves customers who bill federal healthcare benefit programs, including Medicare, Medicaid, and the Children’s Health Insurance Program, as well as private third-party payors and state programs that reimburse items and services. Its market segments include healthcare providers such as physicians—comprising doctors, dentists, optometrists, podiatrists, and chiropractors—other healthcare professionals like physician assistants and nurse practitioners, and teaching hospitals. The company operates within regulatory frameworks governing manufacturers of drugs, devices, biological products, and medical supplies reimbursable under these programs.





Allogene Therapeutics Inc’s Comment on Sales, Marketing and Customers


The company serves customers who bill federal healthcare benefit programs, including Medicare, Medicaid, and the Children’s Health Insurance Program, as well as private third-party payors and state programs that reimburse items and services. Its market segments include healthcare providers such as physicians—comprising doctors, dentists, optometrists, podiatrists, and chiropractors—other healthcare professionals like physician assistants and nurse practitioners, and teaching hospitals. The company operates within regulatory frameworks governing manufacturers of drugs, devices, biological products, and medical supplies reimbursable under these programs.








ALLO's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Allogene Therapeutics Inc 593.72 0.25 -173.76 152
SUBTOTAL 0.00 0.00 0.00 -

Sources: Allogene Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Allogene Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Allogene Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.